TFA Therapeutics annual operating expenses
2021
2022
2023
2024
2025
TFA Therapeutics Operating Expenses Growth & History (RAJAF)
TFA Therapeutics's operating expenses was $901,869 for fiscal 2025.
View full TFA Therapeutics company overviewTFA Therapeutics annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $901,869 | −$188,524 | −17.29% |
| 2024 | 2024-12-31 | $1.1M | $551,839 | +102.47% |
| 2023 | 2023-12-31 | $538,554 | $83,875 | +18.45% |
| 2022 | 2022-12-31 | $454,679 | $335,292 | +280.84% |
| 2021 | 2021-12-31 | $119,387 | — | — |
TFA Therapeutics operating expenses trends
Between the periods ended 2021-12-31 and 2025-12-31, TFA Therapeutics's operating expenses increased from $119,387 to $901,869, a change of $782,482.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review TFA Therapeutics source filings ↗